Treatment for direct carotid-cavernous fistula using endovascular techniques
Endovascular Management of Direct Carotid-cavernous Fistula
This study is testing if a new way to treat direct carotid-cavernous fistulas using minimally invasive techniques can help patients recover better after this condition, which often happens due to trauma.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1 (estimated) |
| Ages | 10 Years to 75 Years |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06091150 on ClinicalTrials.gov |
What this trial studies
This clinical trial focuses on the endovascular management of direct carotid-cavernous fistulas, which are abnormal connections between the carotid artery and the cavernous sinus. The study aims to evaluate the effectiveness of endovascular techniques in treating this condition, which can arise from trauma or other medical issues. Patients with direct type A carotid-cavernous fistulas will be included, while those with severe renal disease or unstable health conditions will be excluded. The trial is conducted at Sohag University in Egypt, where there is a notable incidence of this condition due to high rates of motor vehicle accidents.
Who should consider this trial
Good fit: Ideal candidates for this study are patients diagnosed with direct type A carotid-cavernous fistulas.
Not a fit: Patients with end-stage renal disease, hemodynamic instability, or impaired coagulation profiles may not benefit from this study.
Why it matters
Potential benefit: If successful, this treatment could significantly improve symptoms and quality of life for patients suffering from carotid-cavernous fistulas.
How similar studies have performed: While specific outcomes of similar studies are not detailed, the approach of endovascular management has shown promise in treating vascular conditions.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with direct type of carotid cavernous fistula Exclusion Criteria: * End stage renal disease * haemodynamically unstable patients. * Patients with impaired coagulation profile.
Where this trial is running
Sohag
- Ahmad Tharwat — Sohag, Egypt (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.